The National Biotechnology Development Strategy -2015-2020 was launched by the Hon’ble Union Minister for Science & Technology and Earth Sciences, Dr. Harsh Vardhan in New Delhi on December 30, 2015. The Strategy intends to establish India as a world-class bio-manufacturing hub. It aims at establishing an ecosystem for the development of new biotech products by creating a strong infrastructure for R&D and commercialization, and by empowering India’s human resources scientifically and technologically.
The envisioned mission of the Strategy is:
- To provide impetus to utilizing the knowledge and tools to the advantage of Humanity
- Launch a major well directed mission backed with significant investment for generation of new Biotech Products
- Empower scientifically and technologically India’s incomparable Human Resource
- Create a strong Infrastructure for R&D and Commercialization
- Establish India as a world class Bio-manufacturing Hub
- India’s Central Drugs Standard Control Organization(CDSCO) recently released new guidance for biosimilar developers
- The new document is a slight amendment of previous guidelines issued on 2012 with some important changes which have been tabled for discussion
India’s National IPR was released in May, 2016 with an aim to:
- Generate awareness of IP in the country
- To push IPRs as a marketable financial asset which will promote innovation and entrepreneurship in the country.